Publication | Closed Access

Apigenin reduces human insulin fibrillation in vitro and protects SK-N-MC cells against insulin amyloids

Human Insulin FibrillationInsulin AmyloidsInsulin ManagementDiabetesImmunologyProtein MisfoldingSk-n-mc CellsInsulin DeliveryMedicineCell BiologyInsulin Signaling